Preferential retroviral-mediated transduction of EBV- and CMV-specific T cells after polyclonal T-cell activation

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Graft-versus-host disease, resulting from the T cells present in allogeneic hematopoietic stem cell (HSC) inoculums, can potentially be treated if a suicide gene has been introduced into the donor T cells. However, the diversity and functionality of the transfused T-cell population, including EBV- (EBV-T) and CMV-specific (CMV-T) CD8+ T cells, which are particularly important for immunosuppressed individuals undergoing HSC transplants, are often modified by the gene transfer protocol. Here, we show that following polyclonal T-cell activation, EBV-T and CMV-T cells are preferentially transduced by oncoretroviral vectors, as compared to the bulk CD8+ T-cell population. This preferential transduction is associated with higher surface levels of PiT-2, the receptor for the amphotropic envelope with which the virions are pseudotyped. Moreover, EBV-T and CMV-T cells proliferate more extensively as compared to bulk CD8+ T cells. Thus, retroviral-mediated transduction can be biased toward a given antigenic specificity, even under conditions of polyclonal stimulation. © 2004 Nature Publishing Group All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Sauce, D., Mercier, P., Battini, J. L., Ferrand, C., Certoux, J. M., Manel, N., … Robinet, E. (2004). Preferential retroviral-mediated transduction of EBV- and CMV-specific T cells after polyclonal T-cell activation. Gene Therapy, 11(12), 1019–1022. https://doi.org/10.1038/sj.gt.3302273

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free